Asbesto, la fibra asesina
Asbestos, the deadly fiber
DOI:
https://doi.org/10.15446/revfacmed.v72n1.114819Palabras clave:
Asbesto, Cáncer, Toxicología (es)Asbestos, Cancer, Toxicology (en)
Descargas
El asbesto es un grupo de seis minerales fibrosos de origen natural que por sus propiedades de resistencia al calor y a la corrosión se ha usado para elaborar una gran variedad de productos, principalmente materiales de construcción, productos de fricción, materiales textiles termorresistentes, envases, empaquetaduras y revestimientos. La exposición a este material representa un grave riesgo para la salud, ya que puede producir enfermedades como asbestosis, cáncer de pulmón y mesotelioma, entre otras. Por lo anterior, su uso es cada vez más regulado e incluso ha sido prohibido en cerca de 70 países.
Asbestos is a group of six naturally occurring fibrous minerals that have been used to make a wide variety of products, mainly construction materials, friction materials, heat-resistant fabrics, packaging, gaskets, and coatings, due to their heat and corrosion-resistant properties. Exposure to this material entails a serious health risk, as it can cause diseases such as asbestosis, lung cancer, mesothelioma, among others. Consequently, there is a growing trend towards stricter regulations on its use, and over 70 countries have implemented a ban on it.
editorial
Asbestos, the deadly fiber
Asbesto, la fibra asesina
Open access
How to cite: Navarro-Vargas JR, Villamizar GA. Asbestos, the deadly fiber. Rev. Fac. Med. 2024;72(1):e114819. English. doi: https://doi.org/10.15446/revfacmed.v72n1.114819.
Cómo citar: Navarro-Vargas JR, Villamizar GA. [Asbesto, la fibra asesina]. Rev. Fac. Med. 2024;72(1):e114819. English. doi: https://doi.org/10.15446/revfacmed.v72n1.114819.
Copyright: Copyright: ©2023 Universidad Nacional de Colombia. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, as long as the original author and source are credited.
Asbestos is a group of six naturally occurring fibrous minerals that have been used to make a wide variety of products, mainly construction materials, friction materials, heat-resistant fabrics, packaging, gaskets, and coatings, due to their heat and corrosion-resistant properties.1,2 Exposure to this material entails a serious health risk, as it can cause diseases such as asbestosis, lung cancer, mesothelioma, among others.1-3 Consequently, there is a growing trend towards stricter regulations on its use, and over 70 countries have implemented a ban on it.4
In this regard, Ramada-Rodilla et al.,5 in an umbrella review that included 196 articles published between 1980 and 2021, found that the risk of lung cancer and mesothelioma is low at daily asbestos exposure levels <0.1 f/mL, and this exposure limit, with some variations, has been adopted in several European countries for many years. However, the authors concluded that banning all exposure to this material is the best measure to prevent its negative impact on health. Likewise, West et al.,6 in a follow-up study involving 26 397 asbestos-exposed sheet metal workers examined between 1986 and 2016 in the United States and Canada, found that workers who entered the trade after the implementation of the U.S. environmental and occupational regulations develop asbestos-related nonmalignant respiratory diseases at much lower rates compared with those who entered the trade prior to these regulations. All of this is evidence of the importance of regulatory intervention and ongoing surveillance of this material.
Asbestos has been listed as a group 1 carcinogen by the Agency for Toxic Substances and Disease Registry.7 Accordingly, it has been reported that, worldwide, exposure to this material accounted for 34.52% and 36.80% of deaths related to occupational carcinogens in 2005 and 2015, respectively.8 Moreover, Furuya et al.,9 in a review article on asbestos-related diseases, reported that this material causes about 255 000 deaths (243 223-260 029) every year, of which 233 000 (22 322-242 802) occur due to occupational exposure. In practice, however, most cancers caused by asbestos are not reported, documented, or compensated financially, and in most countries none of these cases are properly identified and indemnified.9
In Latin America, a problem that exacerbates this situation is the quality of statistics on deaths from mesothelioma, as this diagnosis can be problematic.10 According to data from the Colombian Ministry of Health and Social Protection, between 2009 and 2021, 6 435 people were treated in the country’s health services for mesothelioma (International Classification of Diseases [ICD] 10 codes: C450, C451, C452, C457, and C459).11 However, there is a huge discrepancy in the annual reporting of this data; for example, in 2009, only 139 people were treated in the country’s health services due to mesothelioma, while in 2014 this figure rose to 1 532 people.
Patterns of mortality following asbestos exposure have been determined primarily through studies of individuals who have been exposed to asbestos in the workplace.10 On the other hand, some review studies and/or meta-analyses have shown that non-occupational exposure to asbestos is also associated with an increased risk of mesothelioma and other conditions such as lung cancer and pleural and interstitial abnormalities.12-16 This topic has been less studied than asbestos-related cancer from occupational exposure, which may be partially due to the challenges involved in measuring and classifying exposure that occurs outside the occupational setting.
In Colombia, the industrial use of asbestos began in 1942 with the first Eternit plant2 and was regulated in 2011 by means of Resolution 007 issued by the Ministry of Health and Social Protection,17 which adopted the Regulation on Hygiene and Safety of Chrysotile and Other Fibers of Similar Use under the concept of “safe use”, which has been highly controversial. However, given that the adverse effects of asbestos were also documented in the country and that victims of asbestos, such as Ana Cecilia Niño, fought tirelessly to prevent its use,2,18 Law 1968 was enacted in 2019,19 providing that “as of January 1, 2021, it is prohibited to exploit, produce, commercialize, import, distribute or export any type of asbestos and of products made with asbestos in the national territory.” This law was introduced taking into account that there is no safe threshold for exposure to asbestos fibers20 and that all varieties of asbestos are carcinogenic to humans.21
Even though the ban on the use of asbestos in Colombia was an important step towards avoiding its adverse effects, it is still necessary to carry out studies to identify the places where there are still elements made with this material in order to define the best way to dismantle them and closely monitor the victims or people exposed to it. The purpose of this is to comply with Law 1968 of 201919 and to make this ban a reality, as in the European Economic Community countries, Australia, and Japan.
Before concluding, it is worth mentioning that asbestos exposure is a public health problem that can affect anyone, even celebrities. Steve McQueen, an acclaimed American actor and racing driver, died in 1980, at the age of 50, of lung cancer that is suspected to have developed from exposure to the material in his youth, when he worked removing insulation from pipes on a troop ship while serving in the Navy, and also because the suits he wore as a race car driver were coated with the material.
For this reason, environmental regulation and epidemiological surveillance must be strengthened, both in Colombia and worldwide, to control asbestos exposure and prevent associated diseases, including the deadly mesothelioma.
Full Professor, Department of Surgery, Faculty of Medicine, Universidad Nacional de Colombia, Bogotá D.C., Colombia.
Anesthesiologist, Surgery Service, Hospital Universitario Nacional de Colombia, Bogotá D.C., Colombia.
jrnavarrov@unal.edu.co
Guillermo Antonio Villamizar
Director, Fundación Colombia Libre de Asbesto, Bogotá D.C., Colombia.
fundclas@gmail.com
References
1.National Cancer Institute (NCI). Asbestos. Bethesda: NCI; 2022 [cited 2024 April 14]. Available from: https://bit.ly/3Yd6WhW.
2.Villamizar GA, Navarro-Vargas JR. Asbestos in Colombia: Industry versus science and health. Rev. Fac. Med. 2019;67(4):709-13. https://doi.org/mst6.
3.Agency for Toxic Substances and Disease Registry (ATSDR). Health Effects of Asbestos. Atlanta: ATSDR; 2016 [cited 2024 July 22]. Available from: https://bit.ly/4d7QaFc.
4.International Ban Asbestos Secretariat (IBAS). Current Asbestos Bans. London: IBAS; 2022 [cited 2024 July 22]. Available from: https://bit.ly/4bWpVRl.
5.Ramada-Rodilla JM, Calvo-Cerrada B, Serra-Pujadas C, Delclos GL, Benavides FG. Fiber burden and asbestos-related diseases: an umbrella review. Gac Sanit. 2022;36(2):173-83. https://doi.org/gqhqcq.
6.West GH, Sokas RK, Welch LS. Change in prevalence of asbestosrelated disease among sheet metal workers 1986 to 2016. Am J Ind Med. 2019;62(7):609-15. https://doi.org/msq5.
7.International Agency for Research on Cancer (IARC). Arsenic, Metals, Fibres, and Dusts. Volume 100C. A review of human carcinogens. Lyon: IARC; 2012. Available from: https://bit.ly/46xb8vn.
8.GBD 2013 Risk Factors Collaborators; Forouzanfar MH, Alexander L, Ross Anderson H, Bachman VF, Biryukov S, et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1659-724. https://doi.org/f3td5q.
9.Furuya S, Chimed-Ochir O, Takahashi K, David A, Takala J. Global Asbestos Disaster. Int Environ Res Public Health. 2018;15(5):1000. https://doi.org/gdrth6.
10.Pasetto R, Terracini B, Marsili D, Comba P. Occupational Burden of Asbestos-related Cancer in Argentina, Brazil, Colombia, and Mexico. Ann Glob Health. 2014;80(4):263-8. https://doi.org/f6rzxf.
11.Sistema Integrado de Información de la Protección Social. Bodega de datos. Registro Individual de Prestación de Servicios – RIPS [Cited 2023 Aug 28]. Available from: https://minsalud.gov.co/proteccionsocial/Paginas/rips.aspx.
12.Hillerdal G. Mesothelioma: cases associated with non-occupational and low dose exposures. Occup Environ Med. 1999;56(8):505-13. https://doi.org/cd2rtf.
13.Bourdès V, Boffetta P, Pisani P. Environmental exposure to asbestos and risk of pleural mesothelioma: review and meta-analysis. Eur J Epidemiol. 2000;16(5):411-7. https://doi.org/btqmmv.
14.Goswami E, Craven V, Dahlstrom DL, Mowat F. Domestic asbestos exposure: a review of epidemiologic and exposure data. Int J Environ Res Public Health. 2013;10(11):5629-70. https://doi.org/f5q3nx.
15.Liu B, van Gerwen M, Bonassi S, Taioli E; International Association for the Study of Lung Cancer Mesothelioma Task Force. Epidemiology of environmental exposure and malignant mesothelioma. J Thorac Oncol. 2017;12(7):1031-45. https://doi.org/gbm9xw.
16.Marsh GM, Riordan AS, Keeton KA, Benson SM. Non-occupational exposure to asbestos and risk of pleural mesothelioma: review and meta-analysis. Occup Environ Med. 2017;74(11):838-46. https://doi.org/gbzjbn
17.Colombia. Ministerio de Salud y Protección Social. Resolución 007 de 2011 (noviembre 4): Por la cual se adopta el Reglamento de Higiene y Seguridad de Crisotilo y otras Fibras de uso similar. Bogotá D.C.: november 4 2011.
18.Idrovo AJ. La vergüenza y deuda pendiente de los efectos en salud relacionados con asbesto en Colombia. Rev. Univ. Ind. Santander. Salud. 2017;49(1):7-8.
19.Colombia. Congreso de la Republica. Ley 1968 de 2019 (julio 11): Por el cual se prohíbe el uso de asbesto en el territorio nacional y se establecen garantías de protección a la salud de los colombianos. Bogotá D.C.: Diario Oficial 51011; July 11 2019.
20.Zha L, Kitamura Y, Kitamura T, Liu R, Shima M, Kurumatani N, et al. Population-based cohort study on health effects of asbestos exposure in Japan. Cancer Sci. 2019;110(3)1076-84. https://doi.org/msmv.
21.Reid A, Heyworth J, de Klerk N, Musk AW. The mortality of women exposed environmentally and domestically to blue asbestos at Wittenoom, Western Australia. Occup Environ Med. 2008;65(11):743-9. https://doi.org/c9djkg..
Referencias
1. National Cancer Institute (NCI). Asbestos. Bethesda: NCI; 2022 [cited 2024 April 14]. Available from: https://bit.ly/3Yd6WhW.
2. Villamizar GA, Navarro-Vargas JR. Asbestos in Colombia: Industry versus science and health. Rev. Fac. Med. 2019;67(4):709-13. https://doi.org/mst6.
3. Agency for Toxic Substances and Disease Registry (ATSDR). Health Effects of Asbestos. Atlanta: ATSDR; 2016 [cited 2024 July 22]. Available from: https://bit.ly/4d7QaFc.
4. International Ban Asbestos Secretariat (IBAS). Current Asbestos Bans. London: IBAS; 2022 [cited 2024 July 22]. Available from: https://bit.ly/4bWpVRl.
5. Ramada-Rodilla JM, Calvo-Cerrada B, Serra-Pujadas C, Delclos GL, Benavides FG. Fiber burden and asbestos-related diseases: an umbrella review. Gac Sanit. 2022;36(2):173-83. https://doi.org/gqhqcq.
6. West GH, Sokas RK, Welch LS. Change in prevalence of asbestosrelated disease among sheet metal workers 1986 to 2016. Am J Ind Med. 2019;62(7):609-15. https://doi.org/msq5.
7. International Agency for Research on Cancer (IARC). Arsenic, Metals, Fibres, and Dusts. Volume 100C. A review of human carcinogens. Lyon: IARC; 2012. Available from: https://bit.ly/46xb8vn.
8. GBD 2013 Risk Factors Collaborators; Forouzanfar MH, Alexander L, Ross Anderson H, Bachman VF, Biryukov S, et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1659-724. https://doi.org/f3td5q.
9. Furuya S, Chimed-Ochir O, Takahashi K, David A, Takala J. Global Asbestos Disaster. Int Environ Res Public Health. 2018;15(5):1000. https://doi.org/gdrth6.
10. Pasetto R, Terracini B, Marsili D, Comba P. Occupational Burden of Asbestos-related Cancer in Argentina, Brazil, Colombia, and Mexico. Ann Glob Health. 2014;80(4):263-8. https://doi.org/f6rzxf.
11. Sistema Integrado de Información de la Protección Social. Bodega de datos. Registro Individual de Prestación de Servicios – RIPS [Cited 2023 Aug 28]. Available from: https://minsalud.gov.co/proteccionsocial/Paginas/rips.aspx.
12. Hillerdal G. Mesothelioma: cases associated with non-occupational and low dose exposures. Occup Environ Med. 1999;56(8):505-13. https://doi.org/cd2rtf.
13. Bourdès V, Boffetta P, Pisani P. Environmental exposure to asbestos and risk of pleural mesothelioma: review and meta-analysis. Eur J Epidemiol. 2000;16(5):411-7. https://doi.org/btqmmv.
14. Goswami E, Craven V, Dahlstrom DL, Mowat F. Domestic asbestos exposure: a review of epidemiologic and exposure data. Int J Environ Res Public Health. 2013;10(11):5629-70. https://doi.org/f5q3nx.
15. Liu B, van Gerwen M, Bonassi S, Taioli E; International Association for the Study of Lung Cancer Mesothelioma Task Force. Epidemiology of environmental exposure and malignant mesothelioma. J Thorac Oncol. 2017;12(7):1031-45. https://doi.org/gbm9xw.
16. Marsh GM, Riordan AS, Keeton KA, Benson SM. Non-occupational exposure to asbestos and risk of pleural mesothelioma: review and meta-analysis. Occup Environ Med. 2017;74(11):838-46. https://doi.org/gbzjbn
17. Colombia. Ministerio de Salud y Protección Social. Resolución 007 de 2011 (noviembre 4): Por la cual se adopta el Reglamento de Higiene y Seguridad de Crisotilo y otras Fibras de uso similar. Bogotá D.C.: november 4 2011.
18. Idrovo AJ. La vergüenza y deuda pendiente de los efectos en salud relacionados con asbesto en Colombia. Rev. Univ. Ind. Santander. Salud. 2017;49(1):7-8.
19. Colombia. Congreso de la Republica. Ley 1968 de 2019 (julio 11): Por el cual se prohíbe el uso de asbesto en el territorio nacional y se establecen garantías de protección a la salud de los colombianos. Bogotá D.C.: Diario Oficial 51011; July 11 2019.
20. Zha L, Kitamura Y, Kitamura T, Liu R, Shima M, Kurumatani N, et al. Population-based cohort study on health effects of asbestos exposure in Japan. Cancer Sci. 2019;110(3)1076-84. https://doi.org/msmv.
21. Reid A, Heyworth J, de Klerk N, Musk AW. The mortality of women exposed environmentally and domestically to blue asbestos at Wittenoom, Western Australia. Occup Environ Med. 2008;65(11):743-9. https://doi.org/c9djkg.
Cómo citar
APA
ACM
ACS
ABNT
Chicago
Harvard
IEEE
MLA
Turabian
Vancouver
Descargar cita
Licencia
Derechos de autor 2024 Revista de la Facultad de Medicina

Esta obra está bajo una licencia Creative Commons Reconocimiento 3.0 Unported.
-